Data Last Updated: May 31, 2024

Breast

Primary Site Histology
C500-C506, C508-C509 8000-8700, 8982-8983
C501-C506, C508-C509 8720-8790

SSDI Data Items

Name Default Value Used for Staging NAACCR Item Required By
Grade Clinical 9 Yes NAACCR #3843 All
Grade Pathological 9 Yes NAACCR #3844 All
Grade Post Therapy Clin (yc) <BLANK> No NAACCR #1068 COC
NPCR
SEER
Grade Post Therapy Path (yp) <BLANK> No NAACCR #3845 CCCR/Canada
COC
NPCR
SEER
Lymph Nodes Positive Axillary Level I-II X8 Yes NAACCR #3882 All
ER Summary 9 Yes NAACCR #3827 All
ER Percent Positive XX8 No NAACCR #3826 COC
SEER (RC)
ER Allred Score X8 No NAACCR #3828 COC 2018-2022
SEER (RC) 2018-2022
PR Summary 9 Yes NAACCR #3915 All
PR Percent Positive XX8 No NAACCR #3914 COC
SEER (RC)
PR Allred Score X8 No NAACCR #3916 COC 2018-2022
SEER (RC) 2018-2022
HER2 Overall Summary 9 Yes NAACCR #3855 All
HER2 IHC Summary 8 No NAACCR #3850 CCCR/Canada 2018-2020
COC 2018-2020
SEER (RC) 2018-2020
HER2 ISH Summary 8 No NAACCR #3854 CCCR/Canada 2018-2020
COC 2018-2020
SEER (RC) 2018-2020
HER2 ISH DP Ratio XX.8 No NAACCR #3852 COC 2018-2020
SEER (RC) 2018-2020
HER2 ISH DP Copy No XX.8 No NAACCR #3851 COC 2018-2020
SEER (RC) 2018-2020
HER2 ISH SP Copy No XX.8 No NAACCR #3853 COC 2018-2020
SEER (RC) 2018-2020
Ki-67 (MIB-1) XXX.8 No NAACCR #3863 COC
SEER (RC)
Oncotype DX Recur Score - Invasive XX9 Yes NAACCR #3904 All
Oncotype Dx Risk Level - Invasive 8 No NAACCR #3906 COC
SEER (RC)
Oncotype DX Recur Score - DCIS XX8 No NAACCR #3903 COC
SEER (RC)
Oncotype Dx Risk Level - DCIS 8 No NAACCR #3905 COC
SEER (RC)
Multigene Signature Method 8 No NAACCR #3894 COC
SEER
Multigene Signature Result X8 No NAACCR #3895 COC
SEER
Response Neoadjuv Therapy 8 No NAACCR #3922 COC
SEER (RC)